FindTrial
Sign In

Study on Quality of Life and Pharmacoeconomical burden on COVID recovered Diabetes with comorbidities patients

Pharmaceutical Care impact on Health-Related Quality of Life (HRQoL) and Pharmacoeconomical Burden on COVID-Recovered Diabetic Patients with Comorbid Conditions - Nil

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/090954
Enrollment
500
Registered
2025-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Aged greater than 18 years 2.History of confirmed COVID-19 recovery 3.Diagnosed with Type 2 Diabetes Mellitus 4.At least one comorbid condition On pharmacologic treatment for diabetes and comorbidities 5.Able and willing to provide written informed consent

Exclusion criteria

Exclusion criteria: 1.Type 1 Diabetes Mellitus or gestational diabetes 2.Patients with cognitive impairment or severe psychiatric illness 3.Patients receiving investigational drugs or enrolled in other clinical trials 4.Pregnant or lactating women 5.Patients unwilling to participate in follow-up

Design outcomes

Primary

MeasureTime frame
Improving of Health related quality of lifeTimepoint: 1.Baseline (T0): At enrollment 2.3 months(T1):After Pharmaceutical care intervention period 3.6 Months(T2): Long term follow up—

Secondary

MeasureTime frame
Pharmaco economic burden (Direct medical cost, Indirect Medical cost)Timepoint: 1.Base line:(T0) 2.3 Months (T1) 3.6 months (T2);Drug Related problemsTimepoint: Continuous monitoring, summarized at 3 & 6 months—

Countries

India

Contacts

Public ContactSadanandam Akari

Malla Reddy Institute of Pharmacy

sadhapharmd@gmail.com9989535600

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026